Announcements Trials
Browse Landscape

Phase

Phase 4 12Phase 1 7Phase 2 5Phase NA 4Phase 3 3Phase EARLY_PHASE1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1Breast 1

Conditions

Zollinger-Ellison Syndrome 1Vomiting 1Precancerous Conditions 1Nausea 1Esophageal Neoplasms 1Breast Neoplasms 1Barrett Esophagus 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Esomeprazole × Clear all
NCT00357682 2025-05-01

AspECT

University of Oxford

Phase 3 Completed
2,557 enrolled 17 charts
GastrointestinalOther neoplasm

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

NCT00206440 2018-12-06

NEXIUM

Baylor Breast Care Center

Phase 3 Terminated
43 enrolled 5 charts
Breast

Breast Neoplasms, Nausea, Vomiting

NCT00079833 2010-11-19

Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

AstraZeneca

Phase 3 Completed
25 enrolled

Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡